HEAL WELL. AGE WELL. LIVE LONGER.(800) 266-7207   ·   contact@clearhealthpass.com
Media room

There’s a story
worth understanding.

Science, tribal enterprise, healthcare infrastructure and the questions shaping the next generation of regenerative medicine.

Company overview

A starting point
for your reporting.

Clear Health Pass Holdings, LLC acts as authorized Tribal Agent and program manager for the Tribal Biotechnology & Health Consortium. The company has in-market Rampart™ DL Matrix wound-care tissue, a shared documentation platform and planned peptide and healthspan programs.

A text brief with dated status and reporting distinctions. No third-party endorsements are implied.

Media inquiries

Get the context.
Speak to the team.

Request an interview, source documents, product context or clarification of a company statement.

Prepare a media inquiry↗

contact@clearhealthpass.com · (800) 266-7207

Reporting distinctions
In market versus in development

Rampart™ DL Matrix and the measurement app are described as in market. Platform beta layers, the sensing pipeline and the unlaunched peptide pathways have different statuses.

Regulated versus approved

Rampart™ is an FDA-regulated Section 361 HCT/P. It is not FDA-approved or cleared.

Agency receipt versus endorsement

A record of correspondence or evidence receipt does not mean a federal agency endorses the company, agrees with its position or has granted coverage.

Tribal ownership versus company agency

Rampart™ is tribally owned through the Consortium, with CHP acting as agent and licensee under written delegations.

Story leads

All stories↗